S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Privia Health Group (PRVA) Stock Price, News & Analysis

$22.32
0.00 (0.00%)
(As of 03/1/2024 ET)
Today's Range
$22.03
$22.66
50-Day Range
$19.31
$24.22
52-Week Range
$19.17
$30.15
Volume
1.21 million shs
Average Volume
983,249 shs
Market Capitalization
$2.65 billion
P/E Ratio
117.48
Dividend Yield
N/A
Price Target
$30.75

Privia Health Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.91 Rating Score
Upside/​Downside
37.8% Upside
$30.75 Price Target
Short Interest
Healthy
6.48% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.20mentions of Privia Health Group in the last 14 days
Based on 31 Articles This Week
Insider Trading
Selling Shares
$516,812 Sold Last Quarter
Proj. Earnings Growth
46.15%
From $0.26 to $0.38 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

64th out of 950 stocks

Health Services Industry

1st out of 11 stocks


PRVA stock logo

About Privia Health Group Stock (NASDAQ:PRVA)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

PRVA Stock Price History

PRVA Stock News Headlines

Privia Health Group (NASDAQ:PRVA) PT Lowered to $26.00
Privia Health Group (NASDAQ:PRVA) PT Lowered to $29.00
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Privia Health Group (NASDAQ:PRVA) Price Target Cut to $28.00
Forecasting The Future: 4 Analyst Projections For Privia Health Gr
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
RBC Capital Keeps Their Buy Rating on Privia Health Group (PRVA)
Privia Health Gr's Earnings: A Preview
Privia Health Group Inc (PRVA)
PRVA Mar 2024 25.000 call
RBC Capital Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Privia Health Group Inc.
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/03/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.75
High Stock Price Target
$41.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+37.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.91
Research Coverage
11 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
1.75%

Debt

Sales & Book Value

Annual Sales
$1.66 billion
Cash Flow
$0.25 per share
Book Value
$5.12 per share

Miscellaneous

Free Float
50,273,000
Market Cap
$2.65 billion
Optionable
Optionable
Beta
0.84
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives















PRVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price target for 2024?

11 brokerages have issued 1 year price objectives for Privia Health Group's stock. Their PRVA share price targets range from $21.00 to $41.00. On average, they anticipate the company's stock price to reach $30.75 in the next twelve months. This suggests a possible upside of 37.8% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2024?

Privia Health Group's stock was trading at $23.03 on January 1st, 2024. Since then, PRVA shares have decreased by 3.1% and is now trading at $22.32.
View the best growth stocks for 2024 here
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) announced its quarterly earnings data on Tuesday, February, 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by $0.02. The firm earned $440.80 million during the quarter, compared to analysts' expectations of $425.81 million. Privia Health Group had a net margin of 1.39% and a trailing twelve-month return on equity of 3.97%. The company's quarterly revenue was up 21.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.14 earnings per share.

What guidance has Privia Health Group issued on next quarter's earnings?

Privia Health Group issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.9 billion.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.55%), Riverbridge Partners LLC (3.89%), Riverbridge Partners LLC (3.68%), Principal Financial Group Inc. (2.97%), Northern Trust Corp (1.15%) and Franklin Resources Inc. (1.15%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRVA) was last updated on 3/3/2024 by MarketBeat.com Staff